These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15359573)

  • 1. Porcine ear skin as a model for the assessment of transdermal drug delivery to premature neonates.
    Sekkat N; Kalia YN; Guy RH
    Pharm Res; 2004 Aug; 21(8):1390-7. PubMed ID: 15359573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reverse iontophoretic monitoring in premature neonates: feasibility and potential.
    Sekkat N; Naik A; Kalia YN; Glikfeld P; Guy RH
    J Control Release; 2002 May; 81(1-2):83-9. PubMed ID: 11992681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Passive and iontophoretic transdermal delivery of phenobarbital: Implications in paediatric therapy.
    Djabri A; Guy RH; Delgado-Charro MB
    Int J Pharm; 2012 Oct; 435(1):76-82. PubMed ID: 22387370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an in vitro model for premature neonatal skin: biophysical characterization using transepidermal water loss.
    Sekkat N; Kalia YN; Guy RH
    J Pharm Sci; 2004 Dec; 93(12):2936-40. PubMed ID: 15459948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of modulated alternating and direct current iontophoresis on transdermal delivery of lidocaine hydrochloride.
    Bhatia G; Banga AK
    Biomed Res Int; 2014; 2014():537941. PubMed ID: 24959580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of iontophoresis as a drug delivery method for midazolam in pediatrics.
    Djabri A; Guy RH; Delgado-Charro MB
    Eur J Pharm Sci; 2019 Feb; 128():137-143. PubMed ID: 30503379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of vasoactive drugs on transdermal lidocaine iontophoresis.
    Riviere JE; Sage B; Williams PL
    J Pharm Sci; 1991 Jul; 80(7):615-20. PubMed ID: 1941556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the poor iontophoretic transport of lysozyme across the skin: when high charge and high electrophoretic mobility are not enough.
    Dubey S; Kalia YN
    J Control Release; 2014 Jun; 183():35-42. PubMed ID: 24657950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing iontophoretic drug delivery: identification and distribution of the charge-carrying species.
    Marro D; Kalia YN; Delgado-Charro MB; Guy RH
    Pharm Res; 2001 Dec; 18(12):1709-13. PubMed ID: 11785690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
    Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
    Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6 kDa) across intact porcine and human skins.
    Dubey S; Kalia YN
    J Control Release; 2010 Aug; 145(3):203-9. PubMed ID: 20423719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evaluation of the effect of electrotreatment on skin permeability.
    Marra F; Levy JL; Santi P; Kalia YN
    J Cosmet Dermatol; 2008 Jun; 7(2):105-11. PubMed ID: 18482013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring transdermal glucose levels in neonates by passive diffusion: an in vitro porcine skin model.
    Tiangco C; Andar A; Quarterman J; Ge X; Sevilla F; Rao G; Stinchcomb A; Bunge A; Tolosa L
    Anal Bioanal Chem; 2017 May; 409(13):3475-3482. PubMed ID: 28283718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contributions of electromigration and electroosmosis to iontophoretic drug delivery.
    Marro D; Kalia YN; Delgado-Charro MB; Guy RH
    Pharm Res; 2001 Dec; 18(12):1701-8. PubMed ID: 11785689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iontophoretic transdermal delivery of glycyrrhizin: effects of pH, drug concentration, co-ions, current intensity, and chemical enhancers.
    Yamamoto R; Takasuga S; Kominami K; Sutoh C; Kinoshita M; Kanamura K; Takayama K
    Chem Pharm Bull (Tokyo); 2013; 61(12):1275-81. PubMed ID: 24292789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of nalbuphine and its prodrugs across skin by passive diffusion and iontophoresis.
    Sung KC; Fang JY; Hu OY
    J Control Release; 2000 Jun; 67(1):1-8. PubMed ID: 10773323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal delivery of vancomycin hydrochloride: Influence of chemical and physical permeation enhancers.
    Datta D; Panchal DS; Venuganti VVK
    Int J Pharm; 2021 Jun; 602():120663. PubMed ID: 33933644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using transdermal iontophoresis to increase granisetron delivery across skin in vitro and in vivo: effect of experimental conditions and a comparison with other enhancement strategies.
    Cázares-Delgadillo J; Ganem-Rondero A; Quintanar-Guerrero D; López-Castellano AC; Merino V; Kalia YN
    Eur J Pharm Sci; 2010 Mar; 39(5):387-93. PubMed ID: 20096354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of microemulsion microstructures and their relationship to transdermal permeation of model drugs: ketoprofen, lidocaine, and caffeine.
    Zhang J; Michniak-Kohn B
    Int J Pharm; 2011 Dec; 421(1):34-44. PubMed ID: 21959104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal iontophoresis of flufenamic acid loaded PLGA nanoparticles.
    Malinovskaja-Gomez K; Labouta HI; Schneider M; Hirvonen J; Laaksonen T
    Eur J Pharm Sci; 2016 Jun; 89():154-62. PubMed ID: 27131608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.